Journal profile · Immunology
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
ISSN 0393-974X · eISSN 1724-6083 · Biolife SAS · ITALY · Bimonthly · Founded 1987
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS: impact factor 0.25; subscription journal; review about 6 months (community reports); community-reported acceptance: about 75%; 34 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS is published by Biolife SAS. By OpenAlex counts of its recent articles, its largest topics are Cancer-related molecular mechanisms research, MicroRNA in disease regulation and RNA modifications and cancer, together about 32.6% of its articles. Its main subfields are Cancer Research and Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Journal of Biological Regulators & Homeostatic Agents (IF 1.397) is a peer-reviewed journal published every 2 months. The journal publishes original papers describing research in the fields of experimental and clinical medicine, molecular biology, biochemistry, regulatory molecules, cellular immunology and pharmacology.
Source: LetPub
Research area (LetPub): Immunology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology13.2%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology11.3%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology8.1%
- Circular RNAs in diseasesBiochemistry, Genetics and Molecular Biology8%
- Cancer-related gene regulationBiochemistry, Genetics and Molecular Biology4.5%
- Ferroptosis and cancer prognosisMedicine4.1%
- Cytokine Signaling Pathways and InteractionsMedicine4.1%
- Cancer, Lipids, and MetabolismBiochemistry, Genetics and Molecular Biology3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
| Minor | Immunology | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
| Minor | Physiology | Zone 4 |
Top journal: noReview journal: no
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.25LetPub ·
- CiteScore 2026-06
- 1.1LetPub ·
- SJR 2026-06
- 0.19LetPub ·
- SNIP 2026-06
- 0.12LetPub ·
- h-index
- 39LetPub ·
- h-index
- 27OpenAlex ·
- i10-index
- 126OpenAlex ·
- 2-year mean citedness
- 1.29OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 672LetPub ·
Articles by year OpenAlex count · 2,393 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 28 | 28 | 0 |
| 2025 | 34 | 33 | 11 |
| 2024 | 482 | 473 | 691 |
| 2023 | 671 | 657 | 285 |
| 2022 | 363 | 349 | 203 |
| 2021 | 357 | 35 | 1,579 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 6 monthsLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Biolife SAS
- Country or region
- ITALY
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1987
- ISSN
- 0393-974X
- Electronic ISSN
- 1724-6083
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
FAQ
Frequently asked questions about JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
What is the impact factor of JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS?
The latest impact factor listed by LetPub is 0.25; CiteScore 1.1, h-index 27.
How long does peer review take at JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS?
Authors report an average review time of about 6 months; the community-reported acceptance is “about 75%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS?
According to LetPub and DOAJ records, JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS is indexed in Scopus.
Is JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS open access, and what is the APC?
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .